Joana Delgado Silva

Dr. Joana Delgado Silva

Coimbra's Hospital and University Center
+1
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
PDF file
JSJoana Delgado Silva
Joana Delgado Silva
MCMarco Costa
Marco Costa
BGBernard J. Gersh
Bernard J. Gersh
LGLino Manuel Martins Gonçalves
Lino Manuel Martins Gonçalves

1 September 2020 in Clinical Immunology
Verified
Journal Article
Closed access
JSJoana Delgado Silva
Joana Delgado Silva
JAJani Sofia Jesus Almeida
Jani Sofia Jesus Almeida
Paulo Rodrigues-SantosPaulo Rodrigues-Santos
Paulo Rodrigues-Santos
MRManuel Santos Rosa
Manuel Santos Rosa
LGLino Gonçalves
Lino Gonçalves

1 July 2011 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
SBSérgio Barra
Sérgio Barra
RPRui Providencia
Rui Providencia
PGPedro Lourenço Gomes
Pedro Lourenço Gomes
JSJoana Delgado Silva
Joana Delgado Silva
LSLuís Seca
Luís Seca
ALA.M. Leitão-Marques
A.M. Leitão-Marques
Patients with coronary artery disease (CAD) are at increased risk of stroke. The aim of this study was to analyze the prognostic accuracy of selected clinical and laboratory variables in stroke risk prediction following discharge after myocardial infarction (MI). We analyzed 404 consecutive patients (aged 68.1±13.7 years; 63.4% male; 37.4% with diabetes) without previous stroke who were discharged in sinus rhythm after being admitted for MI. The following data were collected: cardiovascular risk factors, admission blood glucose (BG), HbA1c, creatinine, peak troponin levels; glomerular filtration rate (GFR) by the MDRD formula; maximum Killip class; GRACE score for in-hospital and 6-month mortality; and extent of CAD. Patients were followed for two years and each variable was tested as a possible predictor of cerebrovascular events (stroke or transient ischemic attack [TIA]). During follow-up, 27 patients were admitted for stroke or TIA. The presence of diabetes, hypertension, dyslipidemia and previously known CAD, type of MI (STEMI vs NSTEMI) and extent of CAD did not predict cerebrovascular risk. The following variables were associated with higher stroke risk: GFR 1 (p=0.025, OR 2.71, 95% CI 1.10-6.69); GRACE in-hospital mortality >180 (p=0.001, OR 4.09, 95% CI 1.64-10.22); admission BG >140 mg/dl (p=0.001, OR 5.74, 95% CI 1.87-17.58); GRACE 6-month mortality >150 (p=0.001, OR 4.50, 95% CI 1.80-6.27); and peak troponin >42ng/ml (p=0.032, OR 2.64, 95% CI 1.06-6.59). Logistic regression analysis produced a model with the predictors GRACE 6-month mortality >150 (OR 3.26; p=0.014) and admission BG >7.7mmol/l (OR 4.09; p=0.017) that fitted the data well (Hosmer-Lemeshow: p=0.916). In patients with MI, variables known to be predictors of in-hospital mortality, including admission BG, renal function, acute heart failure and GRACE score, were found to be useful predictors of stroke during 2-year follow-up. While both GRACE score for 6-month mortality >150 and admission BG >7.7 mmol/l were independent predictors of stroke, CV risk factors, previously known CAD, and extent of CAD assessed by coronary angiography did not improve stroke risk prediction. This study highlights the need for even more aggressive secondary prevention in patients most at risk.

7 August 2018 in Nefrología
Verified
Journal Article
Open access
PDF file
CMCarla L. Moreira
Carla L. Moreira
JRJoana Rocha
Joana Rocha
MFMargarida Ferreira-Silva
Margarida Ferreira-Silva
JSJoana Delgado Silva
Joana Delgado Silva
MAManuela Barbosa Almeida
Manuela Barbosa Almeida
ACAntónio Cabrita
António Cabrita

24 February 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
JSJoana Delgado Silva
Joana Delgado Silva
Paulo Rodrigues-SantosPaulo Rodrigues-Santos
Paulo Rodrigues-Santos
JAJani Sofia Jesus Almeida
Jani Sofia Jesus Almeida
MSManuel Santos-Rosa
Manuel Santos-Rosa
LGLino Manuel Martins Gonçalves
Lino Manuel Martins Gonçalves
The role of the immune system, and hence inflammation, in the pathophysiology of hypertensive patients is not clear. Until now, most clinical and biochemical parameters have failed to predict a positive response to renal denervation (RDN). Our aim was to evaluate the immune response in a cohort of patients treated by RDN, through the analysis of cytokine, chemokine, and growth factor behavior. A population of 21 resistant hypertension patients, treated by RDN, was evaluated at six months and one year. Response was defined as a drop of ≥5 mmHg in ambulatory blood pressure monitoring. Sixty-seven percent and 81% of patients clinically responded after six months and one year, respectively. There were no complications or safety issues. Plasmatic levels of 45 cytokine, chemokine, and growth factors were quantified at four different times, pre- and post-procedure. Baseline characteristics were similar between groups, except that active smoking was more frequent in non-responders at one year. Regulated on activation, normal T cell expressed, and secreted (RANTES/CCL5) levels were significantly lower in responders, both at baseline and at 30 days (p = 0.037), and a level ≤15,496 pg/mL was the optimal cutoff, for prediction of a response. IL-15, IL-17A, IL-27, and leukemia inhibitory factor varied significantly in time, with an acute rise being observed 24 h after RDN. Our group has previously showed that HLA-DR+ double-negative (DN) T cells were significantly lower in responders. There was a positive correlation between IL-13, -27, and -4, and DN T cells, and a negative correlation between the latter and SDF-1α and TNF-α, at baseline. Low plasmatic levels of the chemokine RANTES/CCL5 was the most significant result associated with RDN response and may help to identify the best candidates among patients with true resistant hypertension. Pro-inflammatory cytokines correlated negatively with DN T cells in responders, a finding compatible with an enhanced inflammatory milieu present in this extremely high cardiovascular risk cohort.

1 September 2018 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
JSJoana Delgado Silva
Joana Delgado Silva
RFRaquel Fernandes
Raquel Fernandes
IPInês R. Pita
Inês R. Pita
FPFrederico Pereira
Frederico Pereira
Miłosz JaguszewskiMiłosz Jaguszewski
Miłosz Jaguszewski
LGLino Manuel Martins Gonçalves
Lino Manuel Martins Gonçalves